BIM
ALDR

Bogle Investment Management’s Alder Biopharmaceuticals ALDR Stock Holding History

Bogle Investment Management’s Portfolio ALDR Stock Details ALDR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-206,040
Closed -$5.95M – 457
2015
Q1 		$5.95M Buy
206,040
+126,455
+159% +$3.47M 0.41% 86
2014
Q4 		$2.31M Buy
79,585
+38,273
+93% +$687K 0.15% 186
2014
Q3 		$523K Buy
+41,312
New +$624K 0.03% 292

Other funds holding ALDR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AAMU
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Bogle Investment Management's ALDR Position: Q2 2015 in Review

Bogle Investment Management sold out of Alder Biopharmaceuticals (ALDR) in Q2 2015, closing a stake of 206,040 shares — an estimated $5.95M sold.

Bogle Investment Management first reported a position in ALDR in Q3 2014 and held it in 3 quarters. The position peaked at $5.95M in Q1 2015. 127 funds tracked by Wall St. Rank hold ALDR as of Q2 2015.

  • Bogle Investment Management reported no remaining Alder Biopharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Bogle Investment Management sold 206,040 Alder Biopharmaceuticals shares in Q2 2015, an estimated $5.95M.
  • Bogle Investment Management first reported a position in Alder Biopharmaceuticals in Q3 2014 and held it in 3 quarters.
  • Bogle Investment Management's Alder Biopharmaceuticals position peaked at $5.95M in Q1 2015.
  • 127 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q2 2015.

Based on Bogle Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.